Literature DB >> 22072085

Investigation of prognostic factors for skin sclerosis and lung function in Japanese patients with early systemic sclerosis: a multicentre prospective observational study.

Minoru Hasegawa1, Yoshihide Asano, Hirahito Endo, Manabu Fujimoto, Daisuke Goto, Hironobu Ihn, Katsumi Inoue, Osamu Ishikawa, Yasushi Kawaguchi, Masataka Kuwana, Yoshinao Muro, Fumihide Ogawa, Tetsuo Sasaki, Hiroki Takahashi, Sumiaki Tanaka, Kazuhiko Takehara, Shinichi Sato.   

Abstract

OBJECTIVE: To clarify the clinical course of SSc in Japanese patients with early-onset disease. It is well known that ethnic variations exist in the clinical features and severity of SSc. However, neither the clinical course nor prognostic factors have been thoroughly investigated in the Japanese population.
METHODS: Ninety-three Japanese patients of early-onset SSc (disease duration: <3 years) with diffuse skin sclerosis and/or interstitial lung disease were registered in a multi-centre observational study. All patients had a physical examination with laboratory tests at their first visit and at each of the three subsequent years. Factors that could predict the severity of skin sclerosis and lung involvement were examined statistically by multiple regression analysis.
RESULTS: Two patients died from SSc-related myocardial involvement and four patients died from other complications during the 3-year study. Among various clinical data assessed, the initial modified Rodnan total skin thickness score (MRSS) and maximal oral aperture were associated positively and negatively with MRSS at Year 3, respectively. Additionally, initial ESR tended to be associated with final MRSS. Pulmonary vital capacity (VC) in the third year was significantly associated with initial %VC. Furthermore, patients with anti-topo I antibody tended to show reduced %VC at Year 3.
CONCLUSIONS: Several possible prognostic factors for skin sclerosis and lung function were detected in Japanese patients with early SSc. Further longitudinal studies of larger populations will be needed to confirm these findings.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22072085     DOI: 10.1093/rheumatology/ker333

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  7 in total

1.  Serum KL-6 and surfactant protein-D as monitoring and predictive markers of interstitial lung disease in patients with systemic sclerosis and mixed connective tissue disease.

Authors:  Hideaki Yamakawa; Eri Hagiwara; Hideya Kitamura; Yumie Yamanaka; Satoshi Ikeda; Akimasa Sekine; Tomohisa Baba; Koji Okudela; Tae Iwasawa; Tamiko Takemura; Kazuyoshi Kuwano; Takashi Ogura
Journal:  J Thorac Dis       Date:  2017-02       Impact factor: 2.895

2.  Prediction of organ involvement and survival in systemic sclerosis patients in the first 5 years from diagnosis.

Authors:  Wieneke Mt van den Hombergh; Hanneke Ka Knaapen-Hans; Frank Hj van den Hoogen; Patricia Carreira; Oliver Distler; Roger Hesselstrand; Nicolas Hunzelmann; Serena Vettori; Jaap Fransen; Madelon C Vonk
Journal:  J Scleroderma Relat Disord       Date:  2019-09-06

3.  The degree of skin involvement identifies distinct lung disease outcomes and survival in systemic sclerosis.

Authors:  Tricia R Cottrell; Robert A Wise; Fredrick M Wigley; Francesco Boin
Journal:  Ann Rheum Dis       Date:  2013-04-20       Impact factor: 19.103

4.  High burden of skin sclerosis is associated with severe organ involvement in patients with systemic sclerosis and systemic sclerosis overlap syndrome.

Authors:  Thapat Wannarong; Chayawee Muangchan
Journal:  Rheumatol Int       Date:  2018-09-11       Impact factor: 2.631

5.  The predictive role of lung ultrasound in progression of scleroderma interstitial lung disease.

Authors:  Maria Ludovica Gasperini; Antonietta Gigante; Andrea Iacolare; Chiara Pellicano; Silvio Lucci; Edoardo Rosato
Journal:  Clin Rheumatol       Date:  2019-07-20       Impact factor: 2.980

6.  Exercise capacity in relation to autoantibodies in systemic sclerosis patients.

Authors:  Fujiko Someya; Naoki Mugii; Tetsutarou Yahata; Takao Nakagawa
Journal:  Rheumatol Int       Date:  2012-11-05       Impact factor: 2.631

7.  Clinical Features of Idiopathic Interstitial Pneumonia with Systemic Sclerosis-Related Autoantibody in Comparison with Interstitial Pneumonia with Systemic Sclerosis.

Authors:  Hideaki Yamakawa; Eri Hagiwara; Hideya Kitamura; Yumie Yamanaka; Satoshi Ikeda; Akimasa Sekine; Tomohisa Baba; Shinichiro Iso; Koji Okudela; Tae Iwasawa; Tamiko Takemura; Kazuyoshi Kuwano; Takashi Ogura
Journal:  PLoS One       Date:  2016-08-26       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.